IBB iShares Biotechnology ETF
US$217.67
-0.11%
Latest close
Trend channel, buy level and 3-month target. Information only, not financial advice.
At the channel ceiling · 12-month channel rising
Price is at the upper line, where it has stalled before.
- 2-year channel
- US$201.93 – US$217.03 · rising, +31% a year
- 12-month channel read from
- US$201.74 – US$216.91 · rising, +29% a year
- Price in channel
- 105% (0% = floor, 100% = ceiling)
- Ceiling overhead
- none — above both ceilings
- Turns bearish below
- US$201.74
- Published levels
- Buy and target are not from this channel — see below.
Price history, with the path projected 3 months forward
Updated 2:45 AM ET (57 h ago)
- Daily close
- Upper trend line (2 years)
- Lower trend line (2 years)
- The same lines over the last 12 months
- Dashed after today: projected 3 months
- Our buy
- Our target
Suggested path
Buy at or below
US$203.73
level as at 16 Nov 2026
Our target
US$223.08
by 27 Jan 2027
Projected move
9.5%
gross, before costs
Price is between our buy and target.
Target: IBB's usual move size (9.5%), the best return per day on this path.
This move size: reached in 30% of 21 past stretches, typically in 90 days. (0.11% per day)
- Upper line touches
- 6
- Lower line touches
- 6
- Fit confidence
- 52%
- Fitted
- 1 Nov 2026
Company information
About iShares Biotechnology ETF
iShares Biotechnology ETF (IBB) is an exchange-traded fund, a series of iShares Trust registered with the SEC (series S000004350), listed on NASDAQ and quoted in USD.
- Country
- United States
Trend lines are fitted to past swing highs and lows and may not continue. Information only, not financial advice.